Outcomes of clomiphene citrate treatment in young hypogonadal men

BJU International

Volumn 110, Issue 4, 2012, Pages 573-578

  Katz, Darren J ^a   Nabulsi, Omar ^a   Tal, Raanan ^a   Mulhall, John P ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

clomiphene; hypogonadism; infertility

Indexed keywords

CLOMIFENE CITRATE; ESTRADIOL; FOLLITROPIN; LUTEINIZING HORMONE; SEX HORMONE BINDING GLOBULIN; TESTOSTERONE;

ADULT; ANDROGEN DEFICIENCY IN AGING MALES QUESTIONNAIRE; ARTICLE; BODY HEIGHT; CLINICAL TRIAL; DRUG EFFICACY; DRUG SAFETY; FOLLITROPIN BLOOD LEVEL; FOLLOW UP; HUMAN; HYPOGONADISM; LUTEINIZING HORMONE BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; MALE INFERTILITY; PRIORITY JOURNAL; PROGNOSIS; PROSPECTIVE STUDY; QUESTIONNAIRE; TESTOSTERONE BLOOD LEVEL; UNSPECIFIED SIDE EFFECT; VARICOCELE;

ADULT; CLOMIPHENE; FERTILITY AGENTS, MALE; GONADAL STEROID HORMONES; HUMANS; HYPOGONADISM; MALE; PROSPECTIVE STUDIES; QUESTIONNAIRES; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84864482613     PISSN: 14644096     EISSN: 1464410X     Source Type: Journal    
DOI: 10.1111/j.1464-410X.2011.10702.x     Document Type: Article

References (32)

1. United States Food and Drug Administration. Skin patch replaces testosterone-treatment for hypogonadism. 1996. [cited 7/20/11]; Available at:. Accessed October 2011
2. Araujo AB, Esche GR, Kupelian V, et al,. Prevalence of symptomatic androgen deficiency in men. J Clin Endocrinol Metab 2007; 92: 4241-7 (Pubitemid 350074738)
3. Maggio M, Basaria S,. Welcoming low testosterone as a cardiovascular risk factor. Int J Impot Res 2009; 21: 261-4
4. Maggi M, Schulman C, Quinton R, Langham S, Uhl-Hochgraeber K,. The burden of testosterone deficiency syndrome in adult men: economic and quality-of-life impact. J Sex Med 2007; 4: 1056-69 (Pubitemid 47079639)
5. Harman SM, Metter EJ, Tobin JD, Pearson J, Blackman MR,. Longitudinal effects of aging on serum total and free testosterone levels in healthy men. Baltimore Longitudinal Study of Aging. J Clin Endocrinol Metab 2001; 86: 724-31 (Pubitemid 32207487)
6. Rhoden EL, Morgentaler A,. Risks of testosterone-replacement therapy and recommendations for monitoring. N Engl J Med 2004; 350: 482-92 (Pubitemid 38133769)
7. Guay AT, Bansal S, Heatley GJ,. Effect of raising endogenous testosterone levels in impotent men with secondary hypogonadism: double blind placebo-controlled trial with clomiphene citrate. J Clin Endocrinol Metab 1995; 80: 3546-52
8. Tenover JS, Bremner WJ,. The effects of normal aging on the response of the pituitary-gonadal axis to chronic clomiphene administration in men. J Androl 1991; 12: 258-63
9. Morley JE, Charlton E, Patrick P, et al,. Validation of a screening questionnaire for androgen deficiency in aging males. Metabolism 2000; 49: 1239-42
10. Morley JE, Kaiser FE, Perry HM 3rd, et al,. Longitudinal changes in testosterone, luteinizing hormone, and follicle-stimulating hormone in healthy older men. Metabolism 1997; 46: 410-3 (Pubitemid 27172090)
11. Hall SA, Esche GR, Araujo AB, et al,. Correlates of low testosterone and symptomatic androgen deficiency in a population-based sample. J Clin Endocrinol Metab 2008; 93: 3870-7
12. Sajid MS, Tonsi A, Baig MK,. Health-related quality of life measurement. Int J Health Care Qual Assur 2008; 21: 365-73
13. Dhindsa S, Prabhakar S, Sethi M, Bandyopadhyay A, Chaudhuri A, Dandona P,. Frequent occurrence of hypogonadotropic hypogonadism in type 2 diabetes. J Clin Endocrinol Metab 2004; 89: 5462-8 (Pubitemid 39518427)
14. Finkelstein JS, Klibanski A, Neer RM, Greenspan SL, Rosenthal DI, Crowley WF Jr,. Osteoporosis in men with idiopathic hypogonadotropic hypogonadism. Ann Intern Med 1987; 106: 354-61 (Pubitemid 17029484)
15. Isidori AM, Giannetta E, Greco EA, et al,. Effects of testosterone on body composition, bone metabolism and serum lipid profile in middle-aged men: a meta-analysis. Clin Endocrinol (Oxf) 2005; 63: 280-93 (Pubitemid 41233445)
16. Shores MM, Matsumoto AM, Sloan KL, Kivlahan DR,. Low serum testosterone and mortality in male veterans. Arch Intern Med 2006; 166: 1660-5 (Pubitemid 44232378)
17. Shores MM, Sloan KL, Matsumoto AM, Moceri VM, Felker B, Kivlahan DR,. Increased incidence of diagnosed depressive illness in hypogonadal older men. Arch Gen Psychiatry 2004; 61: 162-7 (Pubitemid 38146550)
18. Bhasin S, Cunningham GR, Hayes FJ, et al,. Testosterone therapy in adult men with androgen deficiency syndromes: an endocrine society clinical practice guideline. J Clin Endocrinol Metab 2006; 91: 1995-2010 (Pubitemid 43854972)
19. Carrasco D, Prieto M, Pallardo L, et al,. Multiple hepatic adenomas after long-term therapy with testosterone enanthate. Review of the literature. J Hepatol 1985; 1: 573-8
20. Dobs AS, Meikle AW, Arver S, Sanders SW, Caramelli KE, Mazer NA,. Pharmacokinetics, efficacy, and safety of a permeation-enhanced testosterone transdermal system in comparison with bi-weekly injections of testosterone enanthate for the treatment of hypogonadal men. J Clin Endocrinol Metab 1999; 84: 3469-78 (Pubitemid 30645193)
21. Schubert M, Minnemann T, Hubler D, et al,. Intramuscular testosterone undecanoate: pharmacokinetic aspects of a novel testosterone formulation during long-term treatment of men with hypogonadism. J Clin Endocrinol Metab 2004; 89: 5429-34 (Pubitemid 39518421)
22. Kelleher S, Conway AJ, Handelsman DJ,. Influence of implantation site and track geometry on the extrusion rate and pharmacology of testosterone implants. Clin Endocrinol (Oxf) 2001; 55: 531-6 (Pubitemid 32955492)
23. Kelleher S, Turner L, Howe C, Conway AJ, Handelsman DJ,. Extrusion of testosterone pellets: a randomized controlled clinical study. Clin Endocrinol (Oxf) 1999; 51: 469-71 (Pubitemid 29513314)
24. Jordan WP Jr,. Allergy and topical irritation associated with transdermal testosterone administration: a comparison of scrotal and nonscrotal transdermal systems. Am J Contact Dermat 1997; 8: 108-13 (Pubitemid 27237125)
25. Hsiao W, Tenover JL, Ritenour CWM,. The role of testosterone replacement therapy in contemporary urological practice. AUA Update Series, 2008, 27, Lesson 40. Linthicum, MD: American Urological Association, 2008: 385-95
26. Morgentaler A, Dobs AS, Kaufman JM, et al,. Long acting testosterone undecanoate therapy in men with hypogonadism: results of a pharmacokinetic clinical study. J Urol 2008; 180: 2307-13
27. Dohle GR, Smit M, Weber RF,. Androgens and male fertility. World J Urol 2003; 21: 341-5 (Pubitemid 44175249)
28. Turek PJ, Williams RH, Gilbaugh JH 3rd, Lipshultz LI,. The reversibility of anabolic steroid-induced azoospermia. J Urol 1995; 153: 1628-30
29. Shelly W, Draper MW, Krishnan V, Wong M, Jaffe RB,. Selective estrogen receptor modulators: an update on recent clinical findings. Obstet Gynecol Surv 2008; 63: 163-81 (Pubitemid 351612435)
30. Guay AT, Jacobson J, Perez JB, Hodge MB, Velasquez E,. Clomiphene increases free testosterone levels in men with both secondary hypogonadism and erectile dysfunction: who does and does not benefit? Int J Impot Res 2003; 15: 156-65 (Pubitemid 36928907)
31. Shabsigh A, Kang Y, Shabsign R, et al,. Clomiphene citrate effects on testosterone/estrogen ratio in male hypogonadism. J Sex Med 2005; 2: 716-21 (Pubitemid 41742932)
32. Morley JE, Perry HM 3rd, Kevorkian RT, Patrick P,. Comparison of screening questionnaires for the diagnosis of hypogonadism. Maturitas 2006; 53: 424-9